参考文献

参考文献

［1］De Santis M，Becherer A，Bokemeyer C，et al.2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma：an update of the prospective multicentric SEMPET trial［J］.J Clin Oncol，2004，22（6）：1034-1039.

［2］de Wit R.Refining the optimal chemotherapy regimen in good prognosis germ cell cancer：interpretation of the current body of knowledge［J］.J Clin Oncol，2007，25（28）：4346-4349.

［3］Dieckmann K P，Wilken S，Loy V，et al.Treatment of testicular intraepithelial neoplasia（intratubular germ cell neoplasia unspecified）with local radiotherapy or with platinum-based chemotherapy：a survey of the German Testicular Cancer Study Group［J］.Ann Oncol，2013，24（5）：1332-1337.

［4］Germa-Lluch J R，Garcia del Muro X，Maroto P，et al.Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis：the experience of the Spanish Germ-Cell Cancer Group（GG）［J］.Eur Urol，2002，42（6）：553-563.

［5］Gillessen S，Sauve N，Collette L，et al.Predicting outcomes in men with metastatic nonseminomatous germ cell tumors（NSGCT）：results from the IGCCCG Update Consortium［J］.J Clin Oncol，2021.39（14）：1563-1574.

［6］Lorch A，Beyer J，Bascoul B C，et al.Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy［J］.J Clin Oncol，2010，28（33）：4906-4911.

［7］Mead G M，Stenning S P.The International Germ Cell Consensus Classification：a new prognostic factor-based staging classification for metastatic germ cell tumours［J］.Clin Oncol（R Coll Radiol），1997，9（4）：207-209.

［8］Moul J.Timely diagnosis of testicular cancer［J］.Urol Clin North Am，2007，34（2）：109-117.(https://www.daowen.com)

［9］Nason G J，Aditya I，Leao R，et al.Partial orchiectomy：The Princess Margaret cancer centre experience［J］.Urol Oncol，2020.38（6）：605.e19-e24.

［10］Nicolai N，Nicholas T，Francesca G，et al.Laparoscopic retroperitoneal lymph node Dissection for clinical stage Ⅰ nonseminomatous germ cell tumors of the testis：safety and efficacy analyses at a high volume center［J］.J Urol，2018，199（3）：741-747.

［11］Oosterhuis J W，Looijenga L H J.Testicular germ-cell tumours in a broader perspective［J］.Nat Rev Cancer，2005，5（3）：210-212.

［12］Park J S，Jongchan K，Elghiaty A，et al.Recent global trends in testicular cancer incidence and mortality［J］.Medicine（Baltimore），2018，97（37）：e12390.

［13］Patel H D，Gupta M，Cheaib J G，et al.Testis-sparing surgery and scrotal violation for testicular masses suspicious for malignancy：a systematic review and meta-analysis［J］.Urol Oncol，2020，38（5）：344-353.

［14］Ruf C G，Gnoss A，Hartmann M，et al.Contralateral biopsies in patients with testicular germ cell tumours：patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia［J］.Andrology，2015，3（1）：92-98.

［15］Williamso S R，Delahunt B，Magi-Galluzzi C，et al.The World Health Organization 2016 classification of testicular germ cell tumours：a review and update from the International Society of Urological Pathology Testis Consultation Panel［J］.Histopathology，2017.70（3）：335-346.